MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$8,444K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Prepaid expenses and other asset...
Stock-based compensation expense
Income tax payable
Other assets
Negative Cash Flow Breakdown
Accounts payable and accrued exp...
Net loss
Principal payments of insurance ...
Effect of exchange rate changes ...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2025-09-30
2025-06-30
Net loss
-3,303
-32,078
Non-cash operating lease expense
0
224
Stock-based compensation expense
303
2,693
Foreign currency transaction (gain) loss
8
-6
Prepaid expenses and other assets
-704
-67
Accounts payable and accrued expenses
-6,267
596
Research and development incentive receivable
-
59
Income tax payable
195
-227
Lease liability
-1
-227
Other assets
-1
-39
Net cash used in operating activities
-8,317
-28,966
Proceeds from the exercise of stock options
0
16
Principal payments of insurance financing
121
196
Net cash provided by (used in) financing activities
-121
-180
Effect of exchange rate changes on cash and cash equivalents
-6
27
Net decrease in cash and cash equivalents
-8,444
-29,119
Cash and cash equivalents at beginning of period
47,249
-
Cash and cash equivalents at end of period
9,686
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
and cash...
-$8,444K
Prepaid expenses and
other assets
-$704K
Stock-based compensation
expense
$303K
Income tax payable
$195K
Other assets
-$1K
Net cash used in
operating activities
-$8,317K
Net cash provided by
(used in) financing...
-$121K
Effect of exchange rate
changes on cash and cash...
-$6K
Canceled cashflow
$1,203K
Accounts payable and
accrued expenses
-$6,267K
Net loss
-$3,303K
Principal payments of
insurance financing
$121K
Buy us a coffee
LEAP THERAPEUTICS, INC. (LPTX)
LEAP THERAPEUTICS, INC. (LPTX)